Chronic migraine sufferers taking GLP-1 drugs were about 10% less likely to need ER care for a migraine attack compared to those taking a standard first-line migraine drug, researchers are scheduled ...

For people with chronic migraine, starting GLP-1 drugs for conditions like diabetes may be associated with fewer emergency department visits. A preliminary study has found that people who started ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to ...

People whose drinking water came from newer groundwater had a higher risk of developing Parkinson's disease than those whose drinking water came from older groundwater, according to a preliminary ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...

Preliminary study finds GLP-1 drugs (semaglutide, etc.) are associated with 10% fewer emergency visits and lower medication use for chronic migraine patients.

The study looked at 12,370 people with Parkinson's disease and more than 1.2 million people without the disease.

A massive study links newer groundwater and carbonate aquifers to a higher risk of Parkinson’s disease, highlighting the impact of modern pollution on brain health.

Researchers report increasing parental refusal of vitamin K injections at birth. Babies without the shot were 81 times more ...

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency ...

While eThekwini prepares to honour Mandela and Tambo, some residents question whether 10m statues should take priority over ...